LI-3948

• Description :

  IP6K-IN-2 (compound 29c) is an orally bioavailable and blood-brain barrier permeable IP6K inhibitor (IC50: 15.8 nM) that can be used in the study of central nervous system diseases[1].

• UNSPSC :

  12352211

• Target :

  IPK Superfamily

• Type :

  Reference compound

• Related Pathways :

  Metabolic Enzyme/Protease; PI3K/Akt/mTOR

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/li-3948.html

• Smiles :

  FC1=C(C(N)=O)C=CC(N2)=C1[C@]3(CC[C@H](OC4=NC=C(Cl)C=C4Cl)CC3)C2=O

• Molecular Formula :

  C19H16Cl2FN3O3

• Molecular Weight :

  424.25

• References & Citations :

  [1]Identification and Characterization of a Blood–Brain Barrier Penetrant Inositol Hexakisphosphate Kinase (IP6K) Inhibitor

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [3024591-38-3]